Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance.
Alexa Pichet BinetteShorena JanelidzeNicholas CullenJeffrey L DageRandall J BatemanHenrik ZetterbergKaj BlennowErik StomrudNiklas Mattsson-CarlgrenOskar HanssonPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2022)
Creatinine and body mass index (BMI) are related to certain plasma biomarker levels. Adjusting for creatinine and BMI has minor influence on plasma-cerebrospinal fluid (CSF) associations. Adjusting for creatinine and BMI has minor influence on prediction of dementia using plasma biomarkers.